Titan Biotech Limited has fixed September 22, 2026, as the record date for determining shareholder eligibility for the final dividend for financial year 2025-26. The Board of Directors had recommended a payout of ₹0.50 per equity share during its meeting on May 30, 2026.

The proposed dividend is subject to approval by shareholders at the company’s 34th Annual General Meeting (AGM). If approved, the payment will be made after the AGM, subject to deduction of tax at source.

Dividend Details

The intimation was issued pursuant to Regulation 42 of the SEBI Listing Regulations. Shareholders holding equity shares on the record date will be entitled to receive the dividend once ratified by the general body.

Titan Biotech Limited has approved a 1:4 bonus share issue, concluding its board meeting held on September 3, 2026. The directors also finalized the details for the company’s 34th Annual General Meeting (AGM).

The meeting took place at the company’s office in New Delhi. Alongside the bonus issue approval, the board approved the draft notice for the AGM and the director’s report for the fiscal year ended March 31, 2026. They also determined the book closure dates and record dates for shareholder voting.

Agenda Highlights

The board agenda included several key corporate governance items:

• Consider and approve the proposal for issue of bonus shares at 1:4 ratio
• Finalize time, date, and venue for the 34th Annual General Meeting
• Approve draft Notice of AGM and draft Director’s Report with annexures for FY26
• Finalize dates for book closure, record date, and e-voting matters

Trading Window Closure

In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities by designated persons closed on August 31, 2026. It will remain closed until 48 hours after the declaration of the board meeting outcome on September 3, 2026.